TIGIT and neoplasm: TIGIT was expressed on less than 20% of NK cells across all samples, showing little expression variation between tumour and blood-derived cells and was highest on tumour-infiltrating NK cells with a terminally differentiated phenotype (c6; Supplementary Fig. 3g).